Avita Medical earnings were -$57.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest RCEL earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$13.9M, up 19.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RCEL reported annual earnings of -$61.8M, with 74.8% growth. The next RCEL earnings date is Aug 7, 2025.
On RCEL's earnings call on Invalid Date, Avita Medical (NASDAQ: RCEL) reported Q1 2025 earnings per share (EPS) of -$0.53, up 27.4% year over year. Total RCEL earnings for the quarter were -$13.86 million. In the same quarter last year, Avita Medical's earnings per share (EPS) was -$0.73.
The next RCEL earnings call is Invalid Date. Add RCEL to your watchlist to be reminded of Avita Medical's next earnings date.
Is Avita Medical profitable or losing money?
As of the last Avita Medical earnings report, Avita Medical is currently losing money. Avita Medical's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$57.05 million, a 27.28% increase year over year.
What was RCEL's earnings growth in the past year?
As of Avita Medical's earnings date in Invalid Date, Avita Medical's earnings has grown year over year. RCEL earnings in the past year totalled -$57.05 million.
What are Avita Medical's earnings expectations?
The current EPS estimate for Avita Medical's earnings report in Invalid Date is -$0.25.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.